NCLEX® Test Pro 2022

NCLEX® Test Pro 2022
NCLEX® Test Pro 2022
Developer: Estudyme Studio
Category: Medical
40.9K installs
1.1K ratings
+4 weekly installs
trend steady
+17 monthly installs

NCLEX® Test Pro 2022 Summary

NCLEX® Test Pro 2022 is a ad-supported, with in-app purchases Android app in the Medical category, developed by Estudyme Studio. First released 7 years ago(Jan 2018), the app has accumulated 40.9K+ total installs and 1.1K ratings with a 4.70★ (excellent) average rating.

Recent activity: 4 installs this week (17 over 4 weeks) showing strong growth View trends →

Store info: Last updated on Google Play on Sep 29, 2022 .


4.7★

Ratings: 1.1K

5★
4★
3★
2★
1★

Screenshots

App screenshot
App screenshot
App screenshot
App screenshot

App Description

With NCLEX® Test Pro, you can study with our questions and practice test

With NCLEX® Test Pro, you can study for FREE with our NCLEX® practice questions, mock tests and score reports with detailed analytics. Best of all, you can access these features anywhere and anytime when you download our app.

This app helps you learn the critical concepts tested on the NCLEX® Test Pro with detailed practice questions. As you practice questions on NCLEX Test Pro, the app tracks your performance and highlights your test strengths and weaknesses, helping you zero in on what you need to study in order to boost your NCLEX® test score.

Main functions:

- Practice with 2000+ questions covering all sections of NCLEX® RN & NCLEX® PN exam including Labs, Maternity, Med/Surg, Nursing Fundamentals, Pediatrics, Pharmacology, Psych & Mental Health.

- Monitor learning performance and evaluate work

- Detailed statistics of learning progress

- Division of ascending levels

- Daily review calendar based on your study

- Support offline mode

NCLEX® is a registered trademark of the National Council of State Boards of Nursing, Inc. The National Council of State Boards of Nursing, Inc does not endorse, nor is it affiliated in any way with the owner or any content of this application.